PRECISION BIOSCIENCES INC — Director's Dealing 2023

Nov 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-11-02

Reporting Person: Scimeca Dario (General Counsel and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-02	Common Stock	M	55077	—	Acquired	128993	Direct
2023-11-03	Common Stock	S	16023	$0.40	Disposed	112970	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-02	Restricted Stock Units	$	M	55077	Disposed		Common Stock (55077)	Direct

Footnotes

F1: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

F4: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.